Showing results (11-20 of 122) with videos related to
Sort By:
Pageof 13
International Immunology|June 17, 2003
Successful elimination of large established tumors and avoidance of antigen-loss variants by aggressive adoptive T cell immunotherapyKen Matsui, Leigh A O'Mara, Paul M AllenNutrients|February 11, 2023
Dietary Factors and Endometrial Cancer Risk: A Mendelian Randomization StudyXuemin Wang, Dylan M Glubb, Tracy A O'MaraScientific Reports|November 11, 2016
Meta-analysis of gene expression studies in endometrial cancer identifies gene expression profiles associated with aggressive disease and patient outcomeTracy A O'Mara, Min Zhao, Amanda B SpurdleBiomedicines|July 29, 2025
Independent Effects of Hypothyroidism and Obesity on Endometrial Cancer Risk Revealed by Mendelian RandomisationDylan M Glubb, Xuemin Wang, Tracy A O'MaraDevelopmental Medicine and Child Neurology|October 1, 1984
Hand function in cerebral palsy: the effect of hip-flexion angleB R Seeger, D J Caudrey, N A O'MaraCancers|September 29, 2019
Analysis of Promoter-Associated Chromatin Interactions Reveals Biologically Relevant Candidate Target Genes at Endometrial Cancer Risk LociTracy A O'Mara, Amanda B Spurdle, Dylan M Glubb, et al.Journal of Palliative Medicine|April 30, 2005
Integrating palliative care into daily practice: a nursing perspectiveJ Griffie, S Muchka, P Nelson-Marten, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2009
The use of predictive or prognostic genetic biomarkers in endometrial and other hormone-related cancers: justification for extensive candidate gene single nucleotide polymorphism studies of the matrix metalloproteinase family and their inhibitorsTracy A O'Mara, Judith A Clements, Amanda B SpurdleFrontiers in Pharmacology|December 23, 2017
Enhancing the Promise of Drug Repositioning through GeneticsJayne-Louise E Pritchard, Tracy A O'Mara, Dylan M GlubbFrontiers in Pharmacology|May 11, 2017
The Association of CYP19A1 Variation with Circulating Estradiol and Aromatase Inhibitor Outcome: Can CYP19A1 Variants Be Used to Predict Treatment Efficacy?Dylan M Glubb, Tracy A O'Mara, Jannah Shamsani, et al.Pageof 13